Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyoscine butylbromide for shortening first stage of labor
NCT06056869Unknown
- Sponsor
- Ain Shams University
- Start
- Sep 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of hyoscine butylbromide in labor (2 arms), sponsored by Ain Shams University. Primary endpoint: Duration of first stage of labor at 6 months. Status: unknown.
02
Drugs
hyoscine butylbromide
03
Conditions
labor
Beyond the preview
Go deeper on NCT06056869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06056869.